1. Yang R, Li B. UDPG: Maintaining the true nature of sugar. Cell Mol Immunol. 2024 Oct;21(10):1087-1088.
2. Guo Z, Zhang Y, Wang H, Liao L, Ma L, Zhao Y, Yang R, Li X, Niu J, Chu Q, Fu Y, Li B, Yang C. Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle. Nat Commun. 2024 Aug 12;15(1):6915.
3. Guan Y, Li J, Sun B, Xu K, Zhang Y, Ben H, Feng Y, Liu M, Wang S, Gao Y, Duan Z, Zhang Y, Chen D, Wang Y. HBx-induced upregulation of MAP1S drives hepatocellular carcinoma proliferation and migration via MAP1S/Smad/TGF-β1 loop. Int J Biol Macromol. 2024 Nov;281(Pt 3):136327.
4. Xu S, Li H, Gao Y, Wang Y, Zhu B, Shi H, Wang J, Wu X, Wang Y, Shi B, Su Z, Zhang Y, Peng Z, Yu X. Blocking donor liver Pannexin 1 channels facilitates mitochondria protection during liver transplantation. Am J Transplant. 2025 Mar;25(3):489-500.
5. Fan Z, Xu L, Cao Y, Liu T, Tian Y, Pan Z, Mo Y, Wang X, Zhu X, Gao Y, Zhang X, Pan CQ, Wang L, Ren F. One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing. J Med Virol. 2024 Dec;96(12):e70115.
6. Chen S, Cao Y, Fan Z, Xu L, Pan Z, Gao Y, Wei L, Wei Q, Tian Y, Zhang X, Liu M, Ren F. Depressed TFAM promotes acetaminophen-induced hepatotoxicity regulated by DDX3X-PGC1α-NRF2 signaling pathway. Mol Med. 2024 Dec 19;30(1):246.
7. Fan Z, Xu L, Gao Y, Cao Y, Tian Y, Pan Z, Wei L, Chen S, Zhang X, Liu M, Ren F. The cytoplasmic-nuclear transport of DDX3X promotes immune-mediated liver injury in mice regulated by endoplasmic reticulum stress. Cell Death Dis. 2024 Sep 30;15(9):702.
8. Zhang X, Xu L, Fan Z, Gao Y, Tian Y, Cao Y, Chen D, Ren F. Enhancing ASPP2 promotes acute liver injury via an inflammatory immunoregulatory mechanism. Front Immunol. 2024 May 22;15:1381735.
9. Xu F, Luo S, Lu P, Cai C, Li W, Li C. Composition, functions, and applications of exosomal membrane proteins. Front Immunol. 2024 Aug 1;15:1408415.
10. Liu P , Ben H , Guo J ,et al.Highly sensitive single-molecule counting technology for cytokeratin 18 detection in non-alcoholic fatty liver disease using novel antibodies[J].Microchemical Journal, 2024, 198(000):9.DOI:10.1016/j.microc.2024.110155.
11. Han J, Wei FL, Wu HX, Guo LY, Guo S, Han Y, Sun YN, Hou W, Hu ZJ. Clinical evaluation of droplet digital pcr for suspected ascites infection in patients with liver cirrhosis. Hepatol Int. 2024 Aug;18(4):1249-1260.
12. Wang J, Li Q, Huo Y, Liu X, Shi Y, Xie B. ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation. Sci Rep. 2024 Nov 25;14(1):29177.
13. Zhang Y, Yan C, Dong Y, Zhao J, Yang X, Deng Y, Su L, Yin J, Zhang Y, Sun F, Feng Y. ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque. J Adv Res. 2024 May 11:S2090-1232(24)00201-7.
14. Xu X, Jing C, Zhu T, Jiang M, Fu Y, Xie F, Li J, Meng Q. Case report: POEMS syndrome with portal hypertension. Front Med (Lausanne). 2024 Jul 23;11:1373397.
15. Chen X, Wei J, Zhang Y, Zhang Y, Zhang T. Crosstalk between gut microbiome and neuroinflammation in pathogenesis of HIV-associated neurocognitive disorder. J Neurol Sci. 2024 Feb 15;457:122889.
16. Zhang J, Yin J, Wang W, Gao J, Li T, Mou D, Liang L, Meng Q, Feng Y. Reduced neutralizing antibody production against Omicron XBB.1.5 in people living with HIV. Chin Med J (Engl). 2024 Nov 5;137(21):2633-2635.
17. Zhao Y, Yang T, Ouyang Y, Rao W, Liu K, Zheng J, Lv F, Shi Y, Wang F, Liu D, Qiao L, Xia Z, Zhang Y, Chen D, Wang W. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma. Front Immunol. 2024 Jan 29;15:1339213.
18. Wu X, Chan L, Zhu D, Pang Y, Jin M, Wang Y, Wang W. Mitosis targeting in non-small lung cancer cells by inhibition of PAD4. Heliyon. 2024 Mar 8;10(6):e27313.
19. Ma J, Pang Y, Shang Y, Xie C, Xu X, Chan L, Zhang Z, Wang W. CyTOF analysis revealed platelet heterogeneity in breast cancer patients received T-DM1 treatment. Clin Immunol. 2024 Jun;263:110227.
20. Xie C, Chan L, Pang Y, Shang Y, Cao W, Tuohan M, Deng Q, Wang Y, Zhao L, Wang W. Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway. Biomed Pharmacother. 2024 Sep;178:117158.
21. Ya X, Ma L, Liu C, Ge P, Xu Y, Zheng Z, Mou S, Wang R, Zhang Q, Ye X, Zhang D, Zhang Y, Wang W, Li H, Zhao J. Metabolic alterations of peripheral blood immune cells and heterogeneity of neutrophil in intracranial aneurysms patients. Clin Transl Med. 2024 Feb;14(2):e1572.
22. Liu C, Ge P, Zhang B, Chan L, Pang Y, Tao C, Li J, He Q, Liu W, Mou S, Zheng Z, Zhao Z, Sun W, Zhang Q, Wang R, Zhang Y, Wang W, Zhang D, Zhao J. Mass cytometry revealed the circulating immune cell landscape across different Suzuki stages of Moyamoya disease. Immunol Res. 2024 Aug;72(4):654-664.
23. Ya X, Li H, Ge P, Xu Y, Liu Z, Zheng Z, Mou S, Liu C, Zhang Y, Wang R, Zhang Q, Ye X, Wang W, Zhang D, Zhao J. Single-Cell Atlas of Atherosclerosis Patients by Cytof: Circulatory and Local Immune Disorders. Aging Dis. 2024 Feb 1;15(1):245-258.
24. Ge P, Tao C, Wang W, He Q, Liu C, Zheng Z, Mou S, Zhang B, Liu X, Zhang Q, Wang R, Li H, Zhang D, Zhao J. Circulating immune cell landscape and T-cell abnormalities in patients with moyamoya disease. Clin Transl Med. 2024 Apr;14(4):e1647.
25. Ya X, Liu C, Ma L, Ge P, Xu X, Zheng Z, Mou S, Wang R, Zhang Q, Ye X, Zhang D, Zhang Y, Wang W, Li H, Zhao J. Single-cell atlas of peripheral blood by CyTOF revealed peripheral blood immune cells metabolic alterations and neutrophil changes in intracranial aneurysm rupture. MedComm (2020). 2024 Jul 15;5(8):e637
26. Tao C, Liu C, Ge P, Chan L, Pang Y, Li J, He Q, Liu W, Mou S, Zheng Z, Zhang B, Zhao Z, Sun W, Zhang Q, Wang R, Zhang Y, Wang W, Zhang D, Zhao J. T cells immune imbalance presents in patients with multiple intracranial aneurysms. Clin Exp Immunol. 2025 Jan 21;219(1):uxae058.
27. Shang Y, Liu T, Wang W. The potential of lenvatinib in breast cancer therapy. Med Oncol. 2024 Aug 22;41(9):233.
28. Yang Z, Liu S, Wei F, Hu J. The effects of Qingchang Ligan formula on hepatic encephalopathy in mouse model: results from gut microbiome-metabolomics analysis. Front Cell Infect Microbiol. 2024 Aug 16;14:1381209.
29. Zhang L, Cai M, Zhang X, Wang S, Pang L, Chen X, Zheng C, Sun Y, Liang Y, Guo S, Wei F, Zhang Y. Integrated analysis of microbiome and host transcriptome unveils correlations between lung microbiota and host immunity in bronchoalveolar lavage fluid of pneumocystis pneumonia patients. Microbes Infect. 2024 Nov-Dec;26(8):105374.
30. Ding, S., Jin, X., Guo, J. et al. A Biomimetic Asymmetric Structured Intelligent Wound Dressing with Dual-modality Humidity-pressure Sensing for Non-invasive and Real-time Wound Healing Monitoring. Adv. Fiber Mater. 7, 156–171 (2025).
31. Wang X, Yin L, Chai M, Kou B, Liu X, Wang X. Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process. Integr Cancer Ther. 2024 Jan-Dec;23:15347354231226126.
32. Huang M, Chang J, Liu Y, Yin J, Zeng X. Apelin/APJ increased renal blood flow through endothelial BKCa channel induced p-eNOS and ET-1 in diabetic conditions. Peptides. 2025 Jan;183:171333.
33. Ji D, Xiao X, Luo A, Fan X, Ma J, Wang D, Xia M, Ma L, Wang PY, Li W, Chen P. FACT mediates the depletion of macroH2A1.2 to expedite gene transcription. Mol Cell. 2024 Aug 22;84(16):3011-3025.e7.
34. Wu Z, Geng N, Liu Z, Pan W, Zhu Y, Shan J, Shi H, Han Y, Ma Y, Liu B. Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction. Virol J. 2024 Apr 26;21(1):96.
35. Y M , Shanshan Wang ; , Ding H .Bioinformatics analysis and experimental validation of cystathionine-gamma-lyase as a potential prognosis biomarker in hepatocellular carcinoma[J].Biocell, 2024, 48(3).DOI:10.32604/biocell.2024.048244.
36. Wang S, Link F, Munker S, Wang W, Feng R, Liebe R, Li Y, Yao Y, Liu H, Shao C, Ebert MPA, Ding H, Dooley S, Weng HL, Wang SS. Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure. Hepatol Commun. 2024 Jul 18;8(8):e0483.
37. Chen X, Wei J, Zhang M, Su B, Ren M, Cai M, Zhang Y, Zhang T. Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta-analysis. BMC Public Health. 2024 Aug 7;24(1):2145.
38. Chen X, Wei J, Li Z, Zhang Y, Zhang X, Zhang L, Wang X, Zhang Y, Zhang T. Dysregulation of Gut Microbiota-Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus-Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic Analysis. Ann Neurol. 2024 Aug;96(2):306-320.
39. Chen X, Wei J, Zhang M, Su B, Ren M, Cai M, Zhang Y, Zhang T. Prevalence, incidence, and case fatality of tuberculous meningitis in adults living with HIV: a systematic review and meta-analysis. BMC Public Health. 2024 Aug 7;24(1):2145.
40. Wu Z, Cao Y, Liu Z, Geng N, Pan W, Zhu Y, Shi H, Song Q, Liu B, Ma Y. Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital. Ann Med. 2024 Dec;56(1):2415401.
41. Yao Y, Zhang M, Liu D, Liu X, Li Q, Wang X. Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors. Clin Transl Oncol. 2024 Aug 17.
42. Liu BJ, Guan YY, Qiao LX, Zhang JM, Li AJ, Yang PX, Gao YX, Chen DX, Wang CX, Wu J. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway. J Ethnopharmacol. 2024 Jun 12;327:117994.
43. 孫樂(lè)毅,段斌煒. 原發(fā)性肝癌類器官研究進(jìn)展[J]. 中華肝膽外科雜志,2024,30(7):549-552. DOI:10.3760/cma.j.cn113884-20240429-00125.
44. 張宮銘,段斌煒,王欣欣,等. 肝內(nèi)膽管癌空間微環(huán)境單細(xì)胞表型在疾病預(yù)后中的作用[J]. 國(guó)際外科學(xué)雜志,2024,51(12):813-819. DOI:10.3760/cma.j.cn115396-20240720-00228.
45. 潘楨楨,徐玲,張向穎,等. 基于CRISPR/Cas9聯(lián)合Cre-LoxP方法的Ddx3x肝臟條件性敲除小鼠模型的構(gòu)建與鑒定[J]. 胃腸病學(xué)和肝病學(xué)雜志,2024,33(10):1275-1280. DOI:10.3969/j.issn.1006-5709.2024.10.002.
46. 莫胤康,范子豪,任鋒. 肝再生在對(duì)乙酰氨基酚誘導(dǎo)的肝損傷修復(fù)中的作用[J]. 臨床肝膽病雜志,2024,40(9):1902-1907. DOI:10.12449/JCH240929.
47. 曹亞玲,田原,范子豪,等. 基于RAA-CRISPR-Cas13a檢測(cè)KPC型碳青霉烯酶基因方法的建立及評(píng)價(jià)[J]. 中華檢驗(yàn)醫(yī)學(xué)雜志,2024,47(2):159-164. DOI:10.3760/cma.j.cn114452-20231009-00195.
48. 劉海雯,徐玲,范玉,等. 基于微滴式數(shù)字聚合酶鏈?zhǔn)椒磻?yīng)技術(shù)檢測(cè)布魯氏菌病患者血液中布魯氏菌核酸的研究[J]. 疾病監(jiān)測(cè),2024,39(6):751-755. DOI:10.3784/jbjc.202312050637.
49. 孫麗娜,王琪,劉新,等. MLR預(yù)測(cè)PBC相關(guān)肝癌發(fā)生臨床指標(biāo)[J]. 標(biāo)記免疫分析與臨床,2024,31(6):986-991. DOI:10.11748/bjmy.issn.1006-1703.2024.06.002.
50. 林明華,常遠(yuǎn),劉芳,等. 慢性乙型肝炎及肝硬化患者血清血管生成素1、2及其比值變化與HBV DNA和ALT的相關(guān)性分析[J]. 臨床肝膽病雜志,2024,40(6):1126-1129. DOI:10.12449/JCH240609.
51. 高明慧,霍云飛,寇卜心,等. shASPP2 H22穩(wěn)轉(zhuǎn)肝癌細(xì)胞系的構(gòu)建及ASPP2敲低對(duì)H22移植瘤小鼠血管生成的影響[J]. 現(xiàn)代生物醫(yī)學(xué)進(jìn)展,2024,24(11):2043-2051. DOI:10.13241/j.cnki.pmb.2024.11.008.
52. 張洋,謝放. 醫(yī)學(xué)研究生實(shí)驗(yàn)技術(shù)及安全意識(shí)培養(yǎng)的探討[J]. 繼續(xù)醫(yī)學(xué)教育,2024,38(5):131-134. DOI:10.3969/j.issn.1004-6763.2024.05.033.
53. 高明慧,柴夢(mèng)音,寇卜心,等. ASPP2重組腺病毒通過(guò)調(diào)控NF-κB信號(hào)通路抑制DEN誘導(dǎo)的小鼠肝細(xì)胞癌發(fā)生[J]. 實(shí)用肝臟病雜志,2024,27(2):169-173. DOI:10.3969/j.issn.1672-5069.2024.02.003.
54. 蔡玉瑩,殷繼明,高玉雪,等. LC-MS/MS定量檢測(cè)小鼠尿液RNA氧化標(biāo)志物8-oxoGsn[J]. 國(guó)際檢驗(yàn)醫(yī)學(xué)雜志,2024,45(1):109-112. DOI:10.3969/j.issn.1673-4130.2024.01.021.
55. 孫睿,馬佳藝,王珊珊,等. 通過(guò)RNA-seq探究外源性硫化氫對(duì)肝癌細(xì)胞系HepG2的影響[J]. 胃腸病學(xué)和肝病學(xué)雜志,2024,33(12):1625-1630,1635. DOI:10.3969/j.issn.1006-5709.2024.12.009.
56. 李全維,高明慧,寇卜心,等. TP53BP2基因真核表達(dá)載體的構(gòu)建及在人胚腎Expi293F細(xì)胞中蛋白表達(dá)、純化及活性鑒定[J]. 現(xiàn)代檢驗(yàn)醫(yī)學(xué)雜志,2024,39(6):11-17. DOI:10.3969/j.issn.1671-7414.2024.06.002.
57. 肖俐,羅淑敏,徐芳,等. 培養(yǎng)時(shí)間對(duì)小鼠樹(shù)突狀細(xì)胞及其外泌體免疫相關(guān)膜蛋白的影響[J]. 實(shí)用醫(yī)學(xué)雜志,2024,40(7):941-947. DOI:10.3969/j.issn.1006-5725.2024.07.011.
上一篇: 2023年發(fā)表文章列表